Please use this identifier to cite or link to this item: https://doi.org/10.1111/j.1528-1167.2007.01000.x
Title: Anticonvulsive effect of a selective mGluR8 agonist (S)-3,4- dicarboxyphenylglycine (S-3,4-DCPG) in the mouse pilocarpine model of status epilepticus
Authors: Jiang, F.L.
Tang, Y.C.
Chia, S.C.
Jay, T.M.
Tang, F.R. 
Keywords: S-3,4-DCPG
Status epilepticus
Temporal lobe epilepsy
Issue Date: Apr-2007
Citation: Jiang, F.L., Tang, Y.C., Chia, S.C., Jay, T.M., Tang, F.R. (2007-04). Anticonvulsive effect of a selective mGluR8 agonist (S)-3,4- dicarboxyphenylglycine (S-3,4-DCPG) in the mouse pilocarpine model of status epilepticus. Epilepsia 48 (4) : 783-792. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1528-1167.2007.01000.x
Abstract: Purpose: We sought to investigate the anticonvulsive and neuroprotective effect of a selective metabotropic glutamate receptor 8 (mGluR8) agonist (S)-3,4-dicarboxyphenylglycines (S-3,4-DCPG) on pilocarpine-induced status epilepticus (PISE) and subsequent loss of hilar neurons in the dentate gyrus after systemic (intravenous) or local (intracerebroventricular) administration. We compared the difference in granular cell responses after paired-pulse stimulation of the perforant pathway and the sensitivity to local injection of S-3,4-DCPG into the stratum granulosum in the control and mice at 2 months after PISE. Methods: We used intravenous, intracerebroventricular, or intrahippocampal administration of S-3,4-DCPG to mice with status epilepticus or temporal lobe epilepsy and neurophysiologic recording of somatic field excitatory postsynaptic potential (sfEPSP) and population spike (PS) of granular cells in response to perforant-pathway stimulation or S-3,4-DCPG treatment. Results: Intracerebroventricular (1.91 μmol) but not systemic administration of S-3,4-DCPG (at doses of 12.5, 50, 100, 200, 400, 800, and 1,200 mg/kg) could control PISE with no neuroprotective effect. In epileptic mice, mGluR8-mediated inhibition of fEPSPs was reduced significantly in granular cell bodies. Conclusions: At doses ranging from 12.5 to 1,200 mg/kg, intravenous administration of S-3,4-DCPG may not be effective in controlling status epilepticus. Down-regulation of mGluR8 may be related to reduced S-3,4-DCPG-mediated inhibition and the subsequent occurrence of spontaneously recurrent seizures. © 2007 International League Against Epilepsy.
Source Title: Epilepsia
URI: http://scholarbank.nus.edu.sg/handle/10635/108260
ISSN: 00139580
DOI: 10.1111/j.1528-1167.2007.01000.x
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

12
checked on Oct 18, 2019

WEB OF SCIENCETM
Citations

11
checked on Oct 11, 2019

Page view(s)

53
checked on Oct 11, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.